315 related articles for article (PubMed ID: 11278720)
1. Identification of anaplastic lymphoma kinase as a receptor for the growth factor pleiotrophin.
Stoica GE; Kuo A; Aigner A; Sunitha I; Souttou B; Malerczyk C; Caughey DJ; Wen D; Karavanov A; Riegel AT; Wellstein A
J Biol Chem; 2001 May; 276(20):16772-9. PubMed ID: 11278720
[TBL] [Abstract][Full Text] [Related]
2. Midkine binds to anaplastic lymphoma kinase (ALK) and acts as a growth factor for different cell types.
Stoica GE; Kuo A; Powers C; Bowden ET; Sale EB; Riegel AT; Wellstein A
J Biol Chem; 2002 Sep; 277(39):35990-8. PubMed ID: 12122009
[TBL] [Abstract][Full Text] [Related]
3. Effect of single-chain antibody targeting of the ligand-binding domain in the anaplastic lymphoma kinase receptor.
Stylianou DC; Auf der Maur A; Kodack DP; Henke RT; Hohn S; Toretsky JA; Riegel AT; Wellstein A
Oncogene; 2009 Sep; 28(37):3296-306. PubMed ID: 19633684
[TBL] [Abstract][Full Text] [Related]
4. Anti-apoptotic signaling of pleiotrophin through its receptor, anaplastic lymphoma kinase.
Bowden ET; Stoica GE; Wellstein A
J Biol Chem; 2002 Sep; 277(39):35862-8. PubMed ID: 12107166
[TBL] [Abstract][Full Text] [Related]
5. Enhanced antitumorigenic effects in glioblastoma on double targeting of pleiotrophin and its receptor ALK.
Grzelinski M; Steinberg F; Martens T; Czubayko F; Lamszus K; Aigner A
Neoplasia; 2009 Feb; 11(2):145-56. PubMed ID: 19177199
[TBL] [Abstract][Full Text] [Related]
6. Anaplastic lymphoma kinase is activated through the pleiotrophin/receptor protein-tyrosine phosphatase beta/zeta signaling pathway: an alternative mechanism of receptor tyrosine kinase activation.
Perez-Pinera P; Zhang W; Chang Y; Vega JA; Deuel TF
J Biol Chem; 2007 Sep; 282(39):28683-28690. PubMed ID: 17681947
[TBL] [Abstract][Full Text] [Related]
7. Pleiotrophin signaling through anaplastic lymphoma kinase is rate-limiting for glioblastoma growth.
Powers C; Aigner A; Stoica GE; McDonnell K; Wellstein A
J Biol Chem; 2002 Apr; 277(16):14153-8. PubMed ID: 11809760
[TBL] [Abstract][Full Text] [Related]
8. Anaplastic lymphoma kinase: "Ligand Independent Activation" mediated by the PTN/RPTPβ/ζ signaling pathway.
Deuel TF
Biochim Biophys Acta; 2013 Oct; 1834(10):2219-23. PubMed ID: 23777859
[TBL] [Abstract][Full Text] [Related]
9. Recruitment of insulin receptor substrate-1 and activation of NF-kappaB essential for midkine growth signaling through anaplastic lymphoma kinase.
Kuo AH; Stoica GE; Riegel AT; Wellstein A
Oncogene; 2007 Feb; 26(6):859-69. PubMed ID: 16878150
[TBL] [Abstract][Full Text] [Related]
10. Pleiotrophin induces neurite outgrowth and up-regulates growth-associated protein (GAP)-43 mRNA through the ALK/GSK3beta/beta-catenin signaling in developing mouse neurons.
Yanagisawa H; Komuta Y; Kawano H; Toyoda M; Sango K
Neurosci Res; 2010 Jan; 66(1):111-6. PubMed ID: 19833155
[TBL] [Abstract][Full Text] [Related]
11. In contrast to agonist monoclonal antibodies, both C-terminal truncated form and full length form of Pleiotrophin failed to activate vertebrate ALK (anaplastic lymphoma kinase)?
Mathivet T; Mazot P; Vigny M
Cell Signal; 2007 Dec; 19(12):2434-43. PubMed ID: 17904822
[TBL] [Abstract][Full Text] [Related]
12. Anaplastic lymphoma kinase is expressed in different subtypes of human breast cancer.
Perez-Pinera P; Chang Y; Astudillo A; Mortimer J; Deuel TF
Biochem Biophys Res Commun; 2007 Jun; 358(2):399-403. PubMed ID: 17490616
[TBL] [Abstract][Full Text] [Related]
13. Pleiotrophin stimulates fibroblasts and endothelial and epithelial cells and is expressed in human cancer.
Fang W; Hartmann N; Chow DT; Riegel AT; Wellstein A
J Biol Chem; 1992 Dec; 267(36):25889-97. PubMed ID: 1464602
[TBL] [Abstract][Full Text] [Related]
14. Pleiotrophin (PTN) expression and function and in the mouse mammary gland and mammary epithelial cells.
Rosenfield SM; Bowden ET; Cohen-Missner S; Gibby KA; Ory V; Henke RT; Riegel AT; Wellstein A
PLoS One; 2012; 7(10):e47876. PubMed ID: 23077670
[TBL] [Abstract][Full Text] [Related]
15. The receptor protein tyrosine phosphatase (RPTP)beta/zeta is expressed in different subtypes of human breast cancer.
Perez-Pinera P; Garcia-Suarez O; Menendez-Rodriguez P; Mortimer J; Chang Y; Astudillo A; Deuel TF
Biochem Biophys Res Commun; 2007 Oct; 362(1):5-10. PubMed ID: 17706593
[TBL] [Abstract][Full Text] [Related]
16. Suppression of lung adenocarcinoma through menin and polycomb gene-mediated repression of growth factor pleiotrophin.
Gao SB; Feng ZJ; Xu B; Wu Y; Yin P; Yang Y; Hua X; Jin GH
Oncogene; 2009 Nov; 28(46):4095-104. PubMed ID: 19749796
[TBL] [Abstract][Full Text] [Related]
17. A ligand-inducible epidermal growth factor receptor/anaplastic lymphoma kinase chimera promotes mitogenesis and transforming properties in 3T3 cells.
Piccinini G; Bacchiocchi R; Serresi M; Vivani C; Rossetti S; Gennaretti C; Carbonari D; Fazioli F
J Biol Chem; 2002 Jun; 277(25):22231-9. PubMed ID: 11919185
[TBL] [Abstract][Full Text] [Related]
18. Multilevel dysregulation of STAT3 activation in anaplastic lymphoma kinase-positive T/null-cell lymphoma.
Zhang Q; Raghunath PN; Xue L; Majewski M; Carpentieri DF; Odum N; Morris S; Skorski T; Wasik MA
J Immunol; 2002 Jan; 168(1):466-74. PubMed ID: 11751994
[TBL] [Abstract][Full Text] [Related]
19. Activation and inhibition of anaplastic lymphoma kinase receptor tyrosine kinase by monoclonal antibodies and absence of agonist activity of pleiotrophin.
Moog-Lutz C; Degoutin J; Gouzi JY; Frobert Y; Brunet-de Carvalho N; Bureau J; Créminon C; Vigny M
J Biol Chem; 2005 Jul; 280(28):26039-48. PubMed ID: 15886198
[TBL] [Abstract][Full Text] [Related]
20. Identification and characterization of a nuclear interacting partner of anaplastic lymphoma kinase (NIPA).
Ouyang T; Bai RY; Bassermann F; von Klitzing C; Klumpen S; Miething C; Morris SW; Peschel C; Duyster J
J Biol Chem; 2003 Aug; 278(32):30028-36. PubMed ID: 12748172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
